相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Relationship Between Total Lesion Activity on 18F Choline Positron Emission Tomography-Computed Tomography and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Bone Metastases Treated with 223Radium
Luca Filippi et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
Madhav Prasad Yadav et al.
CLINICAL NUCLEAR MEDICINE (2020)
Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison
Ian Alberts et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications
Baozhang Guan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization
Luca Filippi et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
PET imaging of EGFR expression using an 18F-labeled RNA aptamer
Siyuan Cheng et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
Mike Sathekge et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Neuroblastoma - A Neural Crest Derived Embryonal Malignancy
John Inge Johnsen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
Anna Malczewska et al.
ENDOCRINE CONNECTIONS (2019)
Theranostics in Interventional Oncology: Versatile Carriers for Diagnosis and Targeted Image-Guided Minimally Invasive Procedures
Nils Degrauwe et al.
FRONTIERS IN PHARMACOLOGY (2019)
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians
Lisa Bodei et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Major limits of dosimetrically determined activities in advanced differentiated thyroid carcinoma
Monica Finessi et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Efficacy and safety of 177Lutetium-prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer patients: First experience in West Asia - A prospective study
Ramin Akbarian Aghdam et al.
WORLD JOURNAL OF NUCLEAR MEDICINE (2019)
Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy
Ute Hennrich et al.
PHARMACEUTICALS (2019)
The various therapeutic applications of the medical isotope holmium-166: a narrative review
Nienke J. M. Klaassen et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)
The Impact of 68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study
Paul J. Roach et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma
Bin Liu et al.
CLINICAL NUCLEAR MEDICINE (2018)
Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription
Chi Lai Ho et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma
Luca Filippi et al.
FUTURE ONCOLOGY (2018)
Follicular thyroid cancer and Hurthle cell carcinoma: challenges in diagnosis, treatment, and clinical management
Giorgio Grani et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
It is time to move forward into the era of Theranostics
Hojjat Ahmadzadehfar et al.
EJNMMI RESEARCH (2018)
Targeting HER2 in Nuclear Medicine for Imaging and Therapy
Adriana V. F. Massicano et al.
MOLECULAR IMAGING (2018)
An introduction to the clinical practice of theranostics in oncology
J. Harvey Turner
BRITISH JOURNAL OF RADIOLOGY (2018)
Differentiated thyroid cancer theranostics: radioiodine and beyond
Partha S. Choudhury et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth
Alfred Morgenstern et al.
CURRENT RADIOPHARMACEUTICALS (2018)
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
Kambiz Rahbar et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Comparison of Empiric Versus Whole-Body/-Blood Clearance Dosimetry Based Approach to Radioactive Iodine Treatment in Patients with Metastases from Differentiated Thyroid Cancer
Desiree Deandreis et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617
Justin Ferdinandus et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
The reset button revisited: why high activity 131I therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium
Orazio Schillaci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Review: Receptor Targeted Nuclear Imaging of Breast Cancer
Simone U. Dalm et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky et al.
NEOPLASIA (2017)
The Future of Radioligand Therapy: α, β, or Both?
Uwe Haberkorn et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Acute Promyelocytic Leukemia After Treatment of Metastatic Castration-Resistant Prostate Cancer With Radium-223
Ugochukwu Odo et al.
CLINICAL GENITOURINARY CANCER (2017)
Differentiated thyroid carcinoma: Incremental diagnostic value of 131I SPECT/CT over planar whole body scan after radioiodine therapy
Valentina Zilioli et al.
ENDOCRINE (2017)
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
G. Gebhart et al.
ANNALS OF ONCOLOGY (2016)
Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres
Etienne Garin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Molecular response assessed by 68Ga-DOTANOC and survival after 90Y microsphere therapy in patients with liver metastases from neuroendocrine tumours
Luca Filippi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
HER-2 Positive Breast Cancer - a Mini-Review
Hafiz Muhammad Asif et al.
Asian Pacific Journal of Cancer Prevention (2016)
64Cu2+ Ions as PET Probe: An Emerging Paradigm in Molecular Imaging of Cancer
Rubel Chakravarty et al.
MOLECULAR PHARMACEUTICS (2016)
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
Lisa Bodei et al.
SEMINARS IN NUCLEAR MEDICINE (2016)
131I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications
Marguerite T. Parisi et al.
SEMINARS IN NUCLEAR MEDICINE (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Patient-Specific Dosimetry Using Pretherapy [124I]m-iodobenzylguanidine ([124I]mIBG) Dynamic PET/CT Imaging Before [131I]mIBG Targeted Radionuclide Therapy for Neuroblastoma
Shih-ying Huang et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
C. Kratochwil et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Theranostics of Malignant Melanoma with 64CuCl2
Chunxia Qin et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
124Iodine: A Longer-Life Positron Emitter Isotope-New Opportunities in Molecular Imaging
Giuseppe Lucio Cascini et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Aptamers from Cell-Based Selection for Bioanalytical Applications
Weihong Tan et al.
CHEMICAL REVIEWS (2013)
Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group
Gregory A. Yanik et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Thyroid cancer: Surgery for the primary tumor
I. J. Nixon et al.
ORAL ONCOLOGY (2013)
Magnetic Resonance Imaging-Based Radiation-Absorbed Dose Estimation of 166Ho Microspheres in Liver Radioembolization
Peter R. Seevinck et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Radioembolization for hepatocellular carcinoma
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2012)
Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results
Etienne Garin et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study
Maarten L. J. Smits et al.
LANCET ONCOLOGY (2012)
Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer
Joanna Klubo-Gwiezdzinska et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
In vivo biodistribution and accumulation of 89Zr in mice
Diane S. Abou et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Guidelines for the management of castrate-resistant prostate cancer
Fred Saad et al.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2010)
Dosimetry and thyroid cancer: the individual dosage of radioiodine
Michael Lassmann et al.
ENDOCRINE-RELATED CANCER (2010)
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer
Farrokh Dehdashti et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Utilization of 111In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primary in situ therapy
Masaki Kimura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2009)
Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
Jan de Kraker et al.
EUROPEAN JOURNAL OF CANCER (2008)
Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs
M. A. D. Vente et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody
Weibo Cai et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
SPECT/CT with a hybrid camera: a new imaging modality for the functional anatomical mapping of infections
Luca Filippi et al.
EXPERT REVIEW OF MEDICAL DEVICES (2006)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors
DJ Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma
JP Howard et al.
PEDIATRIC BLOOD & CANCER (2005)
Intraoperative gamma probe detection of head and neck paragangliomas with 111In-pentetreotide:: A pilot study
L Filippi et al.
TUMORI JOURNAL (2005)
The biologic basis for neuroblastoma heterogeneity and risk stratification
JM Maris
CURRENT OPINION IN PEDIATRICS (2005)
Patient dosimetry for 131I-MIBG therapy for neuroendocrine tumours based on 123I-MIBG scans
M Monsieurs et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide:: The Rotterdam experience
R Valkema et al.
SEMINARS IN NUCLEAR MEDICINE (2002)
Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma
D Van Nostrand et al.
THYROID (2002)
Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors
Ö Ugur et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
分享论文
